making precision oncology available
to as many cancer patients as possible

CONTACT

ABOUT

precision oncology consulting

Our vision is to enable precision oncology by supporting biotech, pharma, academic centers, diagnostic and therapeutic companies focused on bringing next generation molecular solutions to market and thereby improving cancer patient outcomes.

Precision Oncology Consulting offers an integrated suite of services supporting biotech, pharma, academic centers, diagnostic and therapeutic companies focused on bringing next generation molecular solutions to market and thereby improving patient outcomes.

We have a significant and impressive set of capabilities and resources related to oncology research and collaboration. Our experience in establishing international expert networks, evidence-generating studies and scientific collaborations provides great insight to advancing the field of precision oncology.

With over 18 years of international diagnostic and life science experience, we can support the following oncology technologies and applications:

about_home

Services

End-to-End Market Access Solutions for Precision Oncology Teams

We support biotech, pharma, and diagnostic companies across the full precision oncology market access journey from understanding complex healthcare systems to enabling confident execution and adoption.

Market & System Understanding

Gain a clear understanding of how oncology markets operate, including healthcare system structures, HTA processes, and reimbursement pathways across key markets.

Evidence & Access Strategy

Define the evidence and strategic pathway required to achieve payer acceptance by aligning clinical, economic, and real-world evidence with market access expectations.

search_insights

Value Definition & HTA Execution

Transform product evidence into clear value propositions and HTA-ready materials that support credible payer interactions and reimbursement decisions.

Stakeholder Strategy & Activation

Identify and engage the right institutions, decision-makers, and clinical leaders to support evidence validation, market access, and adoption.

Internal Enablement & Decision-Making

Strengthen collaboration across regulatory, clinical, market access, and commercial teams to support confident decisions and effective execution.

Explore Our Services

LEADERSHIP

SVETLANA NIKIC, PhD
Founder

I help biotechnology and diagnostic companies navigate the complexities of the European healthcare landscape to ensure novel oncology diagnostics reach the patients who need them. My strategic approach is backed by nearly two decades of precision oncology expertise and a proven track record in leadership roles at Roche Diagnostics and Illumina.

VIEW FULL PROFILE

PARTNERS

Noelia Nebot, PhD, Managing Director of Conexias Advisory

Has 15+ years of experience in oncology clinical pharmacology, drug development, and precision medicine. Her expertise includes biomarker applications in trials, global pharma partnerships, and APAC strategic alliances for early-stage biotech.

Kristine Jinnett, PhD, Scientific Communications Consultant

Is a highly experienced medical writer and scientific communications expert with over a decade of experience providing subject matter expertise and strategic content development for renowned companies including Illumina and Natera.

Ozols Audrey

Market Access expert with over 30 years’ experience in molecular diagnostics, medical devices, and pharmaceuticals.  She’s held leadership roles with Exact Sciences, Pfizer, Illumina and Medtronic. Her expertise includes health policy, health economics, reimbursement, and laboratory revenue cycle management.

Strategic Operations Consultant

Combining strong project management skills with expertise in AI agent development, web design, and performance-driven marketing operations. Dedicated to enhancing efficiency through smart systems and digital innovation.

Start a project with Precision Oncology Consulting

Have a challenge in precision oncology?

Let’s explore how we can support your team.

CONTACT US

testimonials

We have recently consulted with Svetlana on a value-based pricing exercise in precision oncology and have been very impressed about the speed she got into the matter, her strategic contribution to the dialogue and her efficiency and diligence in execution - overall a true pleasure to work with her and we look much forward to future engagements.
HELGE LUBENOWCEO, Epignostix, Germany
I had the privilege of collaborating with Svetlana on precision oncology initiatives. Her professionalism, commitment, and scientific acumen are impressive. Svetlana brings together leading stakeholders effectively, benefiting from global interactions. She is a top-notch collaborator, has a great drive to make most of her collaborations and I highly recommend her for strategic initiatives.
HANS VAN SNELLENBERGDirector at Hartwig Medical Foundation
The Netherlands
It has been an immense pleasure to work together with Svetlana over the last 10 years both regarding joint large-scale sequencing projects as well as within international networks focusing on cancer genomics. She has a strong driving force to assist in accelerating the implementation of precision oncology to the benefit of cancer patients. Svetlana is focused, has an enthusiastic way of coordinating activities, and it is always very inspiring to take part of her projects.
RICHARD ROSENQUIST BRANDELLProfessor of Clinical Genetics - Karolinska Institutet
Sweden
What I appreciate about working with Precision Oncology Consulting is not spending lo ts of time over explaining what I need. Their team has worked in industry and understands what my goals are and what I'm looking for. I can give them a high level overview of the topic I would like information on and they give me a highly researched report specific for my needs. It's much more specific to the problems of my organization than the generic high level reports that are on the market.
FRANCHISE LEADGlobal MRD, Illumina 
We engaged Svetlana Nikic and Precision Oncology as part of an initiative to better understand the complex and fragmented reimbursement landscape for oncology genomic testing across Europe. Leveraging a deep expertise in both scientific and commercial, they were able to deliver actionable, market-specific insights that helped build internal business cases. Svetlana brings a rare blend of domain knowledge, regulatory understanding, and practical experience that makes her an invaluable partner for understanding the rapidly evolving field of precision oncology. Highly recommend Precision Oncology for any organization looking to navigate this market.
Director Global Product MarketingOncology Diagnostics
Svetlana has been instrumental in shaping our European market access strategy. She led the development of a robust value dossier and provided structured, country-specific guidance to support reimbursement of our assays. Her deep understanding of oncology diagnostics, evidence requirements, and payer expectations brought clarity and direction to a highly complex process.
Patricia Villagrasa-Gonzalez, PhDCEO & Co-Founder REVEAL GENOMICS, S.L.